Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle

D Lee Hamilton, Craig Beall, Stewart Jeromson, Cyrille Chevtzoff, Daniel J Cuthbertson, Michael L J Ashford (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    7 Citations (Scopus)

    Abstract

    Knockout of Kv1.3 improves glucose homeostasis and confers resistance to obesity. Additionally, Kv1.3 inhibition enhances glucose uptake. This is thought to occur through calcium release. Kv1.3 inhibition in T-lymphocytes alters mitochondrial membrane potential, and, as many agents that induce Ca(2+) release or inhibit mitochondrial function activate AMPK, we hypothesised that Kv1.3 inhibition would activate AMPK and increase glucose uptake. We screened cultured muscle with a range of Kv1.3 inhibitors for their ability to alter glucose uptake. Only Psora4 increased glucose uptake in C2C12 myotubes. None of the inhibitors had any impact on L6 myotubes. Magratoxin activated AMPK in C2C12 myotubes and only Pap1 activated AMPK in the SOL. Kv1.3 inhibitors did not alter cellular respiration, indicating a lack of effect on mitochondrial function. In conclusion, AMPK does not mediate the effects of Kv1.3 inhibitors and they display differential effects in different skeletal muscle cell lines without impairing mitochondrial function.
    Original languageEnglish
    Pages (from-to)13-20
    Number of pages8
    JournalJournal of Physiological Sciences
    Volume64
    Issue number1
    Early online date17 Sep 2013
    DOIs
    Publication statusPublished - Jan 2014

    Fingerprint

    AMP-Activated Protein Kinases
    Muscle Cells
    Skeletal Muscle
    Skeletal Muscle Fibers
    Glucose
    Cell Line
    Cell Respiration
    Mitochondrial Membrane Potential
    Homeostasis
    Obesity
    Calcium
    T-Lymphocytes
    Muscles

    Keywords

    • Ampk
    • Glucose uptake
    • Kv1.3
    • Skeletal muscle

    Cite this

    Hamilton, D Lee ; Beall, Craig ; Jeromson, Stewart ; Chevtzoff, Cyrille ; Cuthbertson, Daniel J ; Ashford, Michael L J. / Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle. In: Journal of Physiological Sciences. 2014 ; Vol. 64, No. 1. pp. 13-20.
    @article{c55edff4477a474abede33ff32a62631,
    title = "Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle",
    abstract = "Knockout of Kv1.3 improves glucose homeostasis and confers resistance to obesity. Additionally, Kv1.3 inhibition enhances glucose uptake. This is thought to occur through calcium release. Kv1.3 inhibition in T-lymphocytes alters mitochondrial membrane potential, and, as many agents that induce Ca(2+) release or inhibit mitochondrial function activate AMPK, we hypothesised that Kv1.3 inhibition would activate AMPK and increase glucose uptake. We screened cultured muscle with a range of Kv1.3 inhibitors for their ability to alter glucose uptake. Only Psora4 increased glucose uptake in C2C12 myotubes. None of the inhibitors had any impact on L6 myotubes. Magratoxin activated AMPK in C2C12 myotubes and only Pap1 activated AMPK in the SOL. Kv1.3 inhibitors did not alter cellular respiration, indicating a lack of effect on mitochondrial function. In conclusion, AMPK does not mediate the effects of Kv1.3 inhibitors and they display differential effects in different skeletal muscle cell lines without impairing mitochondrial function.",
    keywords = "Ampk, Glucose uptake, Kv1.3, Skeletal muscle",
    author = "Hamilton, {D Lee} and Craig Beall and Stewart Jeromson and Cyrille Chevtzoff and Cuthbertson, {Daniel J} and Ashford, {Michael L J}",
    year = "2014",
    month = "1",
    doi = "10.1007/s12576-013-0285-4",
    language = "English",
    volume = "64",
    pages = "13--20",
    journal = "Journal of Physiological Sciences",
    issn = "1880-6546",
    publisher = "Springer Verlag",
    number = "1",

    }

    Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle. / Hamilton, D Lee; Beall, Craig; Jeromson, Stewart; Chevtzoff, Cyrille; Cuthbertson, Daniel J; Ashford, Michael L J (Lead / Corresponding author).

    In: Journal of Physiological Sciences, Vol. 64, No. 1, 01.2014, p. 13-20.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle

    AU - Hamilton, D Lee

    AU - Beall, Craig

    AU - Jeromson, Stewart

    AU - Chevtzoff, Cyrille

    AU - Cuthbertson, Daniel J

    AU - Ashford, Michael L J

    PY - 2014/1

    Y1 - 2014/1

    N2 - Knockout of Kv1.3 improves glucose homeostasis and confers resistance to obesity. Additionally, Kv1.3 inhibition enhances glucose uptake. This is thought to occur through calcium release. Kv1.3 inhibition in T-lymphocytes alters mitochondrial membrane potential, and, as many agents that induce Ca(2+) release or inhibit mitochondrial function activate AMPK, we hypothesised that Kv1.3 inhibition would activate AMPK and increase glucose uptake. We screened cultured muscle with a range of Kv1.3 inhibitors for their ability to alter glucose uptake. Only Psora4 increased glucose uptake in C2C12 myotubes. None of the inhibitors had any impact on L6 myotubes. Magratoxin activated AMPK in C2C12 myotubes and only Pap1 activated AMPK in the SOL. Kv1.3 inhibitors did not alter cellular respiration, indicating a lack of effect on mitochondrial function. In conclusion, AMPK does not mediate the effects of Kv1.3 inhibitors and they display differential effects in different skeletal muscle cell lines without impairing mitochondrial function.

    AB - Knockout of Kv1.3 improves glucose homeostasis and confers resistance to obesity. Additionally, Kv1.3 inhibition enhances glucose uptake. This is thought to occur through calcium release. Kv1.3 inhibition in T-lymphocytes alters mitochondrial membrane potential, and, as many agents that induce Ca(2+) release or inhibit mitochondrial function activate AMPK, we hypothesised that Kv1.3 inhibition would activate AMPK and increase glucose uptake. We screened cultured muscle with a range of Kv1.3 inhibitors for their ability to alter glucose uptake. Only Psora4 increased glucose uptake in C2C12 myotubes. None of the inhibitors had any impact on L6 myotubes. Magratoxin activated AMPK in C2C12 myotubes and only Pap1 activated AMPK in the SOL. Kv1.3 inhibitors did not alter cellular respiration, indicating a lack of effect on mitochondrial function. In conclusion, AMPK does not mediate the effects of Kv1.3 inhibitors and they display differential effects in different skeletal muscle cell lines without impairing mitochondrial function.

    KW - Ampk

    KW - Glucose uptake

    KW - Kv1.3

    KW - Skeletal muscle

    UR - http://www.scopus.com/inward/record.url?scp=84895830891&partnerID=8YFLogxK

    U2 - 10.1007/s12576-013-0285-4

    DO - 10.1007/s12576-013-0285-4

    M3 - Article

    VL - 64

    SP - 13

    EP - 20

    JO - Journal of Physiological Sciences

    JF - Journal of Physiological Sciences

    SN - 1880-6546

    IS - 1

    ER -